Comparison of antihypertensive activity and tolerability of fix-combination irbesartan with hydrochiorothiazide with simple combination in patients with initial mild-moderate essential hypertension
- Author:
- No author available
- Journal Title:
- CHINA MEDICINE
- Issue:
- 5
- DOI:
- 10.3760/cma.j.issn.1673-4777.2011.05.002
- Key Word:
- 高血压;依从性;药物疗法,联合;Hypertension;Compliance;Drug therapy,combination
Abstract： Objecfive To compare the effects of fix-combination with simple combination on the antihypertensive activity and compliance.Methods Totally 160 patients with initial mild-moderate essential hypertension were randomized into two groups:fix-combination or simple combination with irbesartan and hydrochlorothiazide groups.The antihypertensive activity and tolerability within three months were monitored.Results Compared with simple combination(141.3±5.7)mm Hg and(85.5±3.8)mm Hg,fix-combination(139.4±3.6)mm Hg and (83.2±2.1)mm Hg did not further decrease the systolic and diastolic blood pressure within 1 month's treatment (P>0.05).However,3 months later,the systolic blood pressure,the rate of reaching blood pressure target and tolerability were improved more in fix-combination group than that in simple combination group(all P<0.05).Conclusion Fix-combination antihypertensive therapy can increase antihypertensive activity and tolerability in patients with initial mild-moderate essential hypertension.
- [1]赵秀丽,陈捷,崔艳丽,等.中国14省市高血压现状的流行病学研究[J].2006,(16).
- [2]Mitchell L,Julius S,Brunner HR,etc.Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.[J].2004,363(9426).
- [3]Dezii ChristopherM,Tran Michelle,Kawabata Hugh.Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.[J].2002,95(1).
- [4]Giuseppe, Mancia,Guy, De Backer,Anna, Dominiczak,etc.2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).[J].2007,25(6).
- [5]Dahlof Bjorn,Lederballe-Pedersen Ole,Devereux RichardB,etc.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.[J].2002,359(9311).
- [6]Kamalakkannan G,Parkar S,Bangalore S,etc.Fixed-dose combinations improve medication compliance: a meta-analysis.[J].2007,120(8).
- [7]《中国高血压防治指南》修订委员会.中国高血压防治指南[M].2006.